- You can view the full GlaxoSmithKline Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The drug would be the first such treatment in Europe.
Mylan execs have criticized the FDA, which they say has been too slow to approve competitors to complex drugs.
Gold nears two-month high as investors take "safety first" approach
FTSE 100 could see ex-dividend impact at the opening bell.